These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12828337)

  • 21. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW; Josleyn MD; Hooper JW
    Vaccine; 2008 Jun; 26(27-28):3507-15. PubMed ID: 18485547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response.
    Rath A; Choudhury S; Batra D; Kapre SV; Rupprecht CE; Gupta SK
    Virus Res; 2005 Nov; 113(2):143-52. PubMed ID: 15978691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine.
    Vafai A
    Vaccine; 1993; 11(9):937-40. PubMed ID: 8212841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
    Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
    J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.
    Viner KM; Girgis N; Kwak H; Isaacs SN
    Virology; 2007 May; 361(2):356-63. PubMed ID: 17188733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus.
    Feng GH; Liu N; Zhou Y; Zhai YZ; Li XM; Dou XG
    Intervirology; 2007; 50(2):93-8. PubMed ID: 17139185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with plasmid DNA expressing the caprine arthritis-encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein.
    Beyer JC; Chebloune Y; Mselli-Lakhal L; Hötzel I; Kumpula-McWhirter N; Cheevers WP
    Vaccine; 2001 Feb; 19(13-14):1643-51. PubMed ID: 11166887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system.
    Yao Z; Jackson W; Forghani B; Grose C
    J Virol; 1993 Jan; 67(1):305-14. PubMed ID: 8380078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of dairy calves to vaccinia viruses that express foreign genes.
    Gillespie JH; Geissinger C; Scott FW; Higgins WP; Holmes DF; Perkus M; Mercer S; Paoletti E
    J Clin Microbiol; 1986 Feb; 23(2):283-8. PubMed ID: 3700615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.
    Colombage G; Hall R; Pavy M; Lobigs M
    Virology; 1998 Oct; 250(1):151-63. PubMed ID: 9770429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a rubella virus DNA vaccine.
    Pougatcheva SO; Abernathy ES; Vzorov AN; Compans RW; Frey TK
    Vaccine; 1999 Apr; 17(15-16):2104-12. PubMed ID: 10217613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
    Garcia-Valcarcel M; Fowler WJ; Harper DR; Jeffries DJ; Layton GT
    Vaccine; 1997; 15(6-7):709-19. PubMed ID: 9178473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of recombinant herpes simplex virus 1 glycoprotein D candidate vaccines in mice.
    Durmanová V; Mosko T; Sapák M; Kosovský J; Rezuchová I; Buc M; Rajcáni J
    Acta Microbiol Immunol Hung; 2006 Dec; 53(4):459-77. PubMed ID: 17278713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.
    Aberle JH; Aberle SW; Allison SL; Stiasny K; Ecker M; Mandl CW; Berger R; Heinz FX
    J Immunol; 1999 Dec; 163(12):6756-61. PubMed ID: 10586074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme.
    Huemer HP; Strobl B; Nowotny N
    Vaccine; 2000 Jan; 18(14):1320-6. PubMed ID: 10618528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model.
    Learmonth GS; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Arch Virol; 2003 Sep; 148(9):1805-13. PubMed ID: 14505091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
    Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology.
    Thomsson E; Persson L; Grahn A; Snäll J; Ekblad M; Brunhage E; Svensson F; Jern C; Hansson GC; Bäckström M; Bergström T
    J Virol Methods; 2011 Jul; 175(1):53-9. PubMed ID: 21540058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.